As executive director of UMass Chan Medical School's New England Newborn Screening Program (NENSP), Dr. Roger Eaton is responsible for its policy, regulatory, and administrative functions. Under Eaton's leadership since 1998, NENSP was among the first state-mandated programs to apply tandem mass spectrometry (1999) and screen for succinylacetone (2008), severe combined immunodeficiency (2009), and Pompe disease, mucopolysaccharidosis type I (MPS I), X-linked adrenoleukodystrophy (X-ALD), and spinal muscular atrophy (SMA) in 2018.
Eaton joined UMass Chan Medical School from Harvard Medical School, where he specialized in microbiology and immunology. His initial focus at UMass Chan Medical School was the congenital toxoplasmosis screening program.
Eaton is a member of the Association of Public Health Laboratories (APHL) and the International Society of Newborn Screening. He has served on a wide range of national and international workgroups, including the APHL's Steering Committee for the Newborn Screening Technical assistance and Evaluation Program (NewSTEPs) and Health Information Technology Workgroup; the Program Evaluation and Assessment Scheme (HRSA); the European-based SYROCOT study group on toxoplasmosis; the Health Information Technology Workgroup for the U.S. Secretary of Health and Human Services' Advisory Committee on Heritable Disorders in Newborns and Children; the National Coordinating Center for the Genetics and Newborn Screening Regional Collaborative Groups Emergency Preparedness Workgroup; and the Newborn Screening Translational Research Network Laboratory Workgroup.
He has been an invited expert at national conferences on Immunoreactive Trypsinogen testing, G6PD screening, continuity of operations planning for national disasters affecting newborn screening, and electronic transmission of newborn screening hemoglobin results. In addition to serving on regional advisory boards, Eaton has been principal investigator on a three-year HRSA grant (Multicenter Validation of Algorithms to Improve Communications of Positive Newborn Screening Results to the Medical Home) and has served as a project leader on federal grants.
Eaton earned a bachelor's degree from the University of Vermont and a master's degree and a doctorate from the State University of New York. He did his postdoctoral fellowship at Harvard Medical School.
Learn more about Dr. Eaton's academic work.